Management of advanced renal cell carcinoma remains a persistent clinical challenge with high morbidity and mortality for a large proportion of patients. Until recently, available medical ...

Immunohistochemistry showed strong positivity for alpha-methylacyl-CoA racemase (AMACR, Figure 3c), CD 10 (not shown), focal expression of renal cell carcinoma antigen (RCC; Figure 3d) and ...